Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Share :
Published: 5 Dec 2015
Views: 1861
Rating:
Save
Dr Gerald A. Soff - Memorial Sloan Kettering Cancer Center, New York, USA

Dr Soff presents, at a press conference at ASH 2015, results from a quality assessment study looking at enoxaparin dose reduction for thrombocytopenia in patients with cancer.

Read the news story for more information.